UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Clinical laboratory measurement of direct factor Xa inhibitors: anti-Xa assay is preferable to prothrombin time assay

Thrombosis and haemostasis, 2010-12, Vol.104 (6), p.1263-1271

2010

Volltextzugriff (PDF)

Safety, pharmacokinetics and pharmacodynamics of multiple oral doses of apixaban, a factor Xa inhibitor, in healthy subjects

British journal of clinical pharmacology, 2013-11, Vol.76 (5), p.776-786

2013

Volltextzugriff (PDF)

Effect of renal impairment on the pharmacokinetics, pharmacodynamics, and safety of apixaban

Journal of clinical pharmacology, 2016-05, Vol.56 (5), p.637-645

2016

Volltextzugriff (PDF)

Effect of ketoconazole and diltiazem on the pharmacokinetics of apixaban, an oral direct factor Xa inhibitor

British journal of clinical pharmacology, 2015-05, Vol.79 (5), p.838-846

2015

Volltextzugriff (PDF)

Effect of Rifampin on the Pharmacokinetics of Apixaban, an Oral Direct Inhibitor of Factor Xa

American journal of cardiovascular drugs : drugs, devices, and other interventions, 2016-04, Vol.16 (2), p.119-127

2016

Volltextzugriff (PDF)

Evaluation of the effect of naproxen on the pharmacokinetics and pharmacodynamics of apixaban

British journal of clinical pharmacology, 2014-10, Vol.78 (4), p.877-885

2014

Volltextzugriff (PDF)

P005: Atidarsagene autotemcel (hematopoietic stem cell–gene therapy) preserves cognitive and motor development in metachromatic leukodystrophy with up to 12 years follow-up

Genetics in Medicine Open, 2024, Vol.2, p.100882, Article 100882

2024

Volltextzugriff (PDF)

Leydig-Cell Tumors Caused by an Activating Mutation of the Gene Encoding the Luteinizing Hormone Receptor

The New England journal of medicine, 1999-12, Vol.341 (23), p.1731-1736

1999

Volltextzugriff (PDF)

A constitutively activating mutation of the luteinizing hormone receptor in familial male precocious puberty

Nature (London), 1993-10, Vol.365 (6447), p.652-654

1993

Volltextzugriff (PDF)

Activating Mutations of the Stimulatory G Protein in the McCune–Albright Syndrome

The New England journal of medicine, 1991-12, Vol.325 (24), p.1688-1695

1991

Volltextzugriff (PDF)

Effects of Age and Sex on the Single-Dose Pharmacokinetics and Pharmacodynamics of Apixaban

Clinical pharmacokinetics, 2015-06, Vol.54 (6), p.651-662

2015

Volltextzugriff (PDF)

Regional Gastrointestinal Absorption of Apixaban in Healthy Subjects

Journal of clinical pharmacology, 2018-07, Vol.58 (7), p.965-971

2018

Volltextzugriff (PDF)

Newborn Screening and Presymptomatic Treatment of Metachromatic Leukodystrophy

The New England journal of medicine, 2024-10, Vol.391 (13), p.1256-1258

2024

Volltextzugriff (PDF)

Apixaban Single‐Dose Pharmacokinetics, Bioavailability, Renal Clearance, and Pharmacodynamics Following Intravenous and Oral Administration

Clinical pharmacology in drug development, 2021-09, Vol.10 (9), p.974-984

2021

Volltextzugriff (PDF)

Atidarsagene autotemcel (autologous hematopoietic stem cell gene therapy) preserves cognitive and motor development in early-onset metachromatic leukodystrophy with up to 12 years follow-up

Molecular genetics and metabolism, 2024-02, Vol.141 (2), p.107831, Article 107831

2024

Volltextzugriff (PDF)

An Anionic Residue at Position 564 Is Important for Maintaining the Inactive Conformation of the Human Lutropin/Choriogonadotropin Receptor

Molecular pharmacology, 1998-05, Vol.53 (5), p.894

1998

Volltextzugriff (PDF)

The ISIS-TTRRx-CS2 phase 3 study in patients with familial amyloid polyneuropathy: Baseline results of the first 100 patients for the NIS, NIS+7 and mNIS+7 using different methods of scoring: identification of consistencies and key differences

Orphanet journal of rare diseases, 2015-11, Vol.10 (73), p.O22-O22

2015

Volltextzugriff (PDF)

Evaluation of the single-dose pharmacokinetics and pharmacodynamics of apixaban in healthy Japanese and Caucasian subjects

Clinical pharmacology: advances and applications, 2018-01, Vol.10, p.153-163

2018

Volltextzugriff (PDF)

Response to Letter to the Editor From Drs. Stöllberger and Finsterer: Original Publication: “Effect of Renal Impairment on the Pharmacokinetics, Pharmacodynamics, and Safety of Apixaban”

Journal of clinical pharmacology, 2016-05, Vol.56 (5), p.648-649

2016

Volltextzugriff (PDF)

Response to Letter to the Editor From Drs. Stöllberger and Finsterer

Journal of clinical pharmacology, 2016-05, Vol.56 (5), p.648-649

2016

Volltextzugriff (PDF)

Evaluation of the single-dose pharmacokinetics and pharmacodynamics of apixaban in healthy Japanese and Caucasian subjects

Clinical pharmacology: advances and applications, 2018-01, Vol.10, p.153

2018

Volltextzugriff (PDF)

Effect of ketoconazole and diltiazem on the pharmacokinetics of apixaban, an oral direct factor X a inhibitor

British journal of clinical pharmacology, 2015-05, Vol.79 (5), p.838-846

2015

Volltextzugriff (PDF)

Activating mutations of the lutropin choriogonadotropin receptor in precocious puberty

Receptors & channels, 2002, Vol.8 (1), p.3-18

Shenker, Andrew

2002

Volltextzugriff (PDF)

Fibrous dysplasia of bone in the McCune-Albright syndrome: abnormalities in bone formation

The American journal of pathology, 1997-12, Vol.151 (6), p.1587-1600

1997

Volltextzugriff (PDF)

Safety, pharmacokinetics and pharmacodynamics of multiple oral doses of apixaban, a factor X a inhibitor, in healthy subjects

British journal of clinical pharmacology, 2013-11, Vol.76 (5), p.776-786

2013

Volltextzugriff (PDF)

1 – 25 von 89

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(80)
Mit Volltextzugriff
(78)

Publikationsform

1 weiteren anzeigen...

Weniger anzeigen...

Sprache

Englisch
(89)

Erscheinungsjahr

n.n

Thema

Humans
(42)
Science & Technology
(40)
Life Sciences & Biomedicine
(36)
Male
(24)
Biological And Medical Sciences
(21)
Female
(20)
Animals
(18)
Medical Sciences
(15)
Mutation
(15)
Adult
(13)
Molecular Sequence Data
(13)
Amino Acid Sequence
(12)
Pharmacology & Pharmacy
(12)
Adolescent
(8)
Apixaban
(8)
Dose-Response Relationship, Drug
(7)
Fundamental And Applied Biological Sciences. Psychology
(7)
Pyrazoles - Pharmacokinetics
(7)
Pyridones - Pharmacokinetics
(7)
Receptors, Lh - Genetics
(7)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

Menü

Weitere Dienste

Einstellungen

Clinical laboratory measurement of direct factor Xa inhibitors: anti-Xa assay is preferable to prothrombin time assay

Safety, pharmacokinetics and pharmacodynamics of multiple oral doses of apixaban, a factor Xa inhibitor, in healthy subjects

Effect of renal impairment on the pharmacokinetics, pharmacodynamics, and safety of apixaban

Effect of ketoconazole and diltiazem on the pharmacokinetics of apixaban, an oral direct factor Xa inhibitor

Effect of Rifampin on the Pharmacokinetics of Apixaban, an Oral Direct Inhibitor of Factor Xa

Evaluation of the effect of naproxen on the pharmacokinetics and pharmacodynamics of apixaban

P005: Atidarsagene autotemcel (hematopoietic stem cell–gene therapy) preserves cognitive and motor development in metachromatic leukodystrophy with up to 12 years follow-up

Leydig-Cell Tumors Caused by an Activating Mutation of the Gene Encoding the Luteinizing Hormone Receptor

A constitutively activating mutation of the luteinizing hormone receptor in familial male precocious puberty

Activating Mutations of the Stimulatory G Protein in the McCune–Albright Syndrome

Effects of Age and Sex on the Single-Dose Pharmacokinetics and Pharmacodynamics of Apixaban

Regional Gastrointestinal Absorption of Apixaban in Healthy Subjects

Newborn Screening and Presymptomatic Treatment of Metachromatic Leukodystrophy

Apixaban Single‐Dose Pharmacokinetics, Bioavailability, Renal Clearance, and Pharmacodynamics Following Intravenous and Oral Administration

Atidarsagene autotemcel (autologous hematopoietic stem cell gene therapy) preserves cognitive and motor development in early-onset metachromatic leukodystrophy with up to 12 years follow-up

An Anionic Residue at Position 564 Is Important for Maintaining the Inactive Conformation of the Human Lutropin/Choriogonadotropin Receptor

The ISIS-TTRRx-CS2 phase 3 study in patients with familial amyloid polyneuropathy: Baseline results of the first 100 patients for the NIS, NIS+7 and mNIS+7 using different methods of scoring: identification of consistencies and key differences

Evaluation of the single-dose pharmacokinetics and pharmacodynamics of apixaban in healthy Japanese and Caucasian subjects

Response to Letter to the Editor From Drs. Stöllberger and Finsterer: Original Publication: “Effect of Renal Impairment on the Pharmacokinetics, Pharmacodynamics, and Safety of Apixaban”

Response to Letter to the Editor From Drs. Stöllberger and Finsterer

Evaluation of the single-dose pharmacokinetics and pharmacodynamics of apixaban in healthy Japanese and Caucasian subjects

Effect of ketoconazole and diltiazem on the pharmacokinetics of apixaban, an oral direct factor X a inhibitor

Activating mutations of the lutropin choriogonadotropin receptor in precocious puberty

Fibrous dysplasia of bone in the McCune-Albright syndrome: abnormalities in bone formation

Safety, pharmacokinetics and pharmacodynamics of multiple oral doses of apixaban, a factor X a inhibitor, in healthy subjects

Suchergebnisse filtern